RedHill Biopharma (RDHL) FCF Margin (2012 - 2022)
RedHill Biopharma (RDHL) reported FCF Margin of 18.92% for Q4 2022, up 4839.0% year-over-year from 0.38% in Q4 2021, and up 44.72% quarter-over-quarter from 34.22% in Q3 2022.
RedHill Biopharma (RDHL) FCF Margin (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has 10 years of FCF Margin data on file, last reported at 18.92% in Q4 2022.
- FCF Margin for Q4 2022 came in at 18.92%, up 4839.0% year-over-year; the trailing twelve-month figure through Jun 2023 was 23.58% (up 4886.0% YoY), and the FY2025 annual result was 2512.59%, down 240161.0% from the prior year.
- FCF Margin climbed to 18.92% in Q4 2022 per RDHL's latest filing, from 34.22% in the prior quarter.
- Over five years, FCF Margin peaked at 18.92% in Q4 2022 and troughed at 983.14% in Q1 2020.
- A 5-year average of 297.97% and a median of 88.72% in 2021 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2018 and 2020: FCF Margin soared 163564 bps in 2018, then slumped 54981 bps in 2020.
- A 5-year view of FCF Margin shows it stood at 602.58% in 2018, then sank by 44 bps to 870.19% in 2019, then soared by 93 bps to 58.97% in 2020, then retreated by 14 bps to 67.31% in 2021, then surged by 72 bps to 18.92% in 2022.
- Business Quant data shows RDHL's FCF Margin at 18.92% in Q4 2022, 34.22% in Q3 2022, and 89.49% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -429.96% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 32.62% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 13.24% |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -18.92% |
| Sep 30, 2022 | -34.22% |
| Jun 30, 2022 | -89.49% |
| Mar 31, 2022 | -31.61% |
| Dec 31, 2021 | -67.31% |
| Sep 30, 2021 | -87.94% |
| Jun 30, 2021 | -87.88% |
| Mar 31, 2021 | -59.19% |
| Dec 31, 2020 | -58.97% |
| Sep 30, 2020 | -43.00% |
| Jun 30, 2020 | -71.82% |
| Mar 31, 2020 | -983.14% |
| Dec 31, 2019 | -870.19% |
| Sep 30, 2019 | -634.76% |
| Jun 30, 2019 | -660.59% |
| Mar 31, 2019 | -433.33% |
| Dec 31, 2018 | -602.58% |
| Sep 30, 2018 | -379.37% |
| Jun 30, 2018 | -357.32% |
| Mar 31, 2018 | -387.85% |